SCHEMBL22270622

SCHEMBL22270622

CCN(CC)c1nccnc1-c1ccc(N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.46
▸ CYP3A4 P08684 3/20 0.46
▸ TDP1 Q9NUW8 3/20 0.46
▸ TSHR P16473 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ PSMD14 O00487 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ GFER P55789 1/20 0.46
▸ PDE3B Q13370 1/20 0.39
▸ PDE3A Q14432 1/20 0.39
▸ SMN1; SMN2 Q16637 5/20 0.34
▸ LMNA P02545 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ NOS1 P29475 1/20 0.34
▸ TP53 P04637 2/20 0.33
▸ CYP17A1 P05093 1/20 0.33
▸ CYP19A1 P11511 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10726634 0.74 ALDH1A1 (0.53) ALDH1A1CYP3A4TDP1TSHRMAPK1
SCHEMBL18484543 0.73 SMN1; SMN2 (0.49) ALDH1A1CYP3A4TDP1TSHRL3MBTL1
SCHEMBL18447913 0.72 LMNA (0.43) SMN1; SMN2LMNAHTTRAB9AHIF1A
SCHEMBL18448785 0.71 KCNH2 (0.41) ALDH1A1CYP3A4TDP1MAPK1PDE3B
SCHEMBL7567323 0.70 LMNA (0.33) ALDH1A1CYP3A4TDP1TSHRL3MBTL1
SCHEMBL18448354 0.70 ACHE (0.56) ALDH1A1CYP3A4TDP1TSHRL3MBTL1
SCHEMBL19205656 0.68 EGFR (0.40) ALDH1A1CYP3A4TDP1PDE3BPDE3A
SCHEMBL19205814 0.68 EGFR (0.40) ALDH1A1CYP3A4TDP1PDE3BPDE3A
SCHEMBL19205658 0.68 EGFR (0.40) ALDH1A1CYP3A4TDP1PDE3BPDE3A
SCHEMBL18449598 0.67 CYP3A4 (0.61) ALDH1A1CYP3A4TDP1TSHRPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3686187-A1 PROCESS FOR THE PREPARATION OF ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2020-07-29 — — EP disclosed
Send feedback